The study found that for women with "triple-negative" breast cancer, adding Keytruda to standard chemotherapy improved their odds of responding.
from WebMD Health https://ift.tt/32yBlbM
via IFTTT
The study found that for women with "triple-negative" breast cancer, adding Keytruda to standard chemotherapy improved their odds of responding.
No comments:
Post a Comment